A Comparative Endocrine Trans-Differentiation Approach to Pancreatic Ductal Adenocarcinoma Cells with Different EMT Phenotypes Identifies Quasi-Mesenchymal Tumor Cells as Those with Highest Plasticity

Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive and therapy-resistant cancer types which is largely due to tumor heterogeneity, cancer cell de-differentiation, and early metastatic spread. The major molecular subtypes of PDAC are designated classical/epithelial (E) and quasi-me...

Full description

Bibliographic Details
Main Authors: Paula M. Schmidtlein, Clara Volz, Rüdiger Braun, Isabel Thürling, Olha Lapshyna, Ulrich F. Wellner, Björn Konukiewitz, Hendrik Lehnert, Jens-Uwe Marquardt, Hendrik Ungefroren
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/13/18/4663
_version_ 1797519953735188480
author Paula M. Schmidtlein
Clara Volz
Rüdiger Braun
Isabel Thürling
Olha Lapshyna
Ulrich F. Wellner
Björn Konukiewitz
Hendrik Lehnert
Jens-Uwe Marquardt
Hendrik Ungefroren
author_facet Paula M. Schmidtlein
Clara Volz
Rüdiger Braun
Isabel Thürling
Olha Lapshyna
Ulrich F. Wellner
Björn Konukiewitz
Hendrik Lehnert
Jens-Uwe Marquardt
Hendrik Ungefroren
author_sort Paula M. Schmidtlein
collection DOAJ
description Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive and therapy-resistant cancer types which is largely due to tumor heterogeneity, cancer cell de-differentiation, and early metastatic spread. The major molecular subtypes of PDAC are designated classical/epithelial (E) and quasi-mesenchymal (QM) subtypes, with the latter having the worst prognosis. Epithelial–mesenchymal transition (EMT) and the reverse process, mesenchymal-epithelial transition (MET), are involved in regulating invasion/metastasis and stem cell generation in cancer cells but also early pancreatic endocrine differentiation or de-differentiation of adult pancreatic islet cells in vitro, suggesting that pancreatic ductal exocrine and endocrine cells share common EMT programs. Using a panel of PDAC-derived cell lines classified by epithelial/mesenchymal expression as either E or QM, we compared their trans-differentiation (TD) potential to endocrine progenitor or β cell-like cells since studies with human pancreatic cancer cells for possible future TD therapy in PDAC patients are not available so far. We observed that QM cell lines responded strongly to TD culture using as inducers 5′-aza-2′-deoxycytidine or growth factors/cytokines, while their E counterparts were refractory or showed only a weak response. Moreover, the gain of plasticity was associated with a decrease in proliferative and migratory activities and was directly related to epigenetic changes acquired during selection of a metastatic phenotype as revealed by TD experiments using the paired isogenic COLO 357-L3.6pl model. Our data indicate that a QM phenotype in PDAC coincides with increased plasticity and heightened trans-differentiation potential to activate a pancreatic β cell-specific transcriptional program. We strongly assume that this specific biological feature has potential to be exploited clinically in TD-based therapy to convert metastatic PDAC cells into less malignant or even benign cells.
first_indexed 2024-03-10T07:50:05Z
format Article
id doaj.art-2e3015c15dde4909ac6d9b44db7c0960
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-10T07:50:05Z
publishDate 2021-09-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-2e3015c15dde4909ac6d9b44db7c09602023-11-22T12:18:42ZengMDPI AGCancers2072-66942021-09-011318466310.3390/cancers13184663A Comparative Endocrine Trans-Differentiation Approach to Pancreatic Ductal Adenocarcinoma Cells with Different EMT Phenotypes Identifies Quasi-Mesenchymal Tumor Cells as Those with Highest PlasticityPaula M. Schmidtlein0Clara Volz1Rüdiger Braun2Isabel Thürling3Olha Lapshyna4Ulrich F. Wellner5Björn Konukiewitz6Hendrik Lehnert7Jens-Uwe Marquardt8Hendrik Ungefroren9First Department of Medicine, Campus Lübeck, University Hospital Schleswig-Holstein, D-23538 Lübeck, GermanyFirst Department of Medicine, Campus Lübeck, University Hospital Schleswig-Holstein, D-23538 Lübeck, GermanyClinic for Surgery, Campus Lübeck, University Hospital Schleswig-Holstein, D-23538 Lübeck, GermanyFirst Department of Medicine, Campus Lübeck, University Hospital Schleswig-Holstein, D-23538 Lübeck, GermanyClinic for Surgery, Campus Lübeck, University Hospital Schleswig-Holstein, D-23538 Lübeck, GermanyClinic for Surgery, Campus Lübeck, University Hospital Schleswig-Holstein, D-23538 Lübeck, GermanyInstitute of Pathology, Campus Kiel, University Hospital Schleswig-Holstein, D-24105 Kiel, GermanyUniversity of Salzburg, A-5020 Salzburg, AustriaFirst Department of Medicine, Campus Lübeck, University Hospital Schleswig-Holstein, D-23538 Lübeck, GermanyFirst Department of Medicine, Campus Lübeck, University Hospital Schleswig-Holstein, D-23538 Lübeck, GermanyPancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive and therapy-resistant cancer types which is largely due to tumor heterogeneity, cancer cell de-differentiation, and early metastatic spread. The major molecular subtypes of PDAC are designated classical/epithelial (E) and quasi-mesenchymal (QM) subtypes, with the latter having the worst prognosis. Epithelial–mesenchymal transition (EMT) and the reverse process, mesenchymal-epithelial transition (MET), are involved in regulating invasion/metastasis and stem cell generation in cancer cells but also early pancreatic endocrine differentiation or de-differentiation of adult pancreatic islet cells in vitro, suggesting that pancreatic ductal exocrine and endocrine cells share common EMT programs. Using a panel of PDAC-derived cell lines classified by epithelial/mesenchymal expression as either E or QM, we compared their trans-differentiation (TD) potential to endocrine progenitor or β cell-like cells since studies with human pancreatic cancer cells for possible future TD therapy in PDAC patients are not available so far. We observed that QM cell lines responded strongly to TD culture using as inducers 5′-aza-2′-deoxycytidine or growth factors/cytokines, while their E counterparts were refractory or showed only a weak response. Moreover, the gain of plasticity was associated with a decrease in proliferative and migratory activities and was directly related to epigenetic changes acquired during selection of a metastatic phenotype as revealed by TD experiments using the paired isogenic COLO 357-L3.6pl model. Our data indicate that a QM phenotype in PDAC coincides with increased plasticity and heightened trans-differentiation potential to activate a pancreatic β cell-specific transcriptional program. We strongly assume that this specific biological feature has potential to be exploited clinically in TD-based therapy to convert metastatic PDAC cells into less malignant or even benign cells.https://www.mdpi.com/2072-6694/13/18/4663pancreatic ductal adenocarcinomaplasticityquasi-mesenchymalepithelialtrans-differentiationendocrine
spellingShingle Paula M. Schmidtlein
Clara Volz
Rüdiger Braun
Isabel Thürling
Olha Lapshyna
Ulrich F. Wellner
Björn Konukiewitz
Hendrik Lehnert
Jens-Uwe Marquardt
Hendrik Ungefroren
A Comparative Endocrine Trans-Differentiation Approach to Pancreatic Ductal Adenocarcinoma Cells with Different EMT Phenotypes Identifies Quasi-Mesenchymal Tumor Cells as Those with Highest Plasticity
Cancers
pancreatic ductal adenocarcinoma
plasticity
quasi-mesenchymal
epithelial
trans-differentiation
endocrine
title A Comparative Endocrine Trans-Differentiation Approach to Pancreatic Ductal Adenocarcinoma Cells with Different EMT Phenotypes Identifies Quasi-Mesenchymal Tumor Cells as Those with Highest Plasticity
title_full A Comparative Endocrine Trans-Differentiation Approach to Pancreatic Ductal Adenocarcinoma Cells with Different EMT Phenotypes Identifies Quasi-Mesenchymal Tumor Cells as Those with Highest Plasticity
title_fullStr A Comparative Endocrine Trans-Differentiation Approach to Pancreatic Ductal Adenocarcinoma Cells with Different EMT Phenotypes Identifies Quasi-Mesenchymal Tumor Cells as Those with Highest Plasticity
title_full_unstemmed A Comparative Endocrine Trans-Differentiation Approach to Pancreatic Ductal Adenocarcinoma Cells with Different EMT Phenotypes Identifies Quasi-Mesenchymal Tumor Cells as Those with Highest Plasticity
title_short A Comparative Endocrine Trans-Differentiation Approach to Pancreatic Ductal Adenocarcinoma Cells with Different EMT Phenotypes Identifies Quasi-Mesenchymal Tumor Cells as Those with Highest Plasticity
title_sort comparative endocrine trans differentiation approach to pancreatic ductal adenocarcinoma cells with different emt phenotypes identifies quasi mesenchymal tumor cells as those with highest plasticity
topic pancreatic ductal adenocarcinoma
plasticity
quasi-mesenchymal
epithelial
trans-differentiation
endocrine
url https://www.mdpi.com/2072-6694/13/18/4663
work_keys_str_mv AT paulamschmidtlein acomparativeendocrinetransdifferentiationapproachtopancreaticductaladenocarcinomacellswithdifferentemtphenotypesidentifiesquasimesenchymaltumorcellsasthosewithhighestplasticity
AT claravolz acomparativeendocrinetransdifferentiationapproachtopancreaticductaladenocarcinomacellswithdifferentemtphenotypesidentifiesquasimesenchymaltumorcellsasthosewithhighestplasticity
AT rudigerbraun acomparativeendocrinetransdifferentiationapproachtopancreaticductaladenocarcinomacellswithdifferentemtphenotypesidentifiesquasimesenchymaltumorcellsasthosewithhighestplasticity
AT isabelthurling acomparativeendocrinetransdifferentiationapproachtopancreaticductaladenocarcinomacellswithdifferentemtphenotypesidentifiesquasimesenchymaltumorcellsasthosewithhighestplasticity
AT olhalapshyna acomparativeendocrinetransdifferentiationapproachtopancreaticductaladenocarcinomacellswithdifferentemtphenotypesidentifiesquasimesenchymaltumorcellsasthosewithhighestplasticity
AT ulrichfwellner acomparativeendocrinetransdifferentiationapproachtopancreaticductaladenocarcinomacellswithdifferentemtphenotypesidentifiesquasimesenchymaltumorcellsasthosewithhighestplasticity
AT bjornkonukiewitz acomparativeendocrinetransdifferentiationapproachtopancreaticductaladenocarcinomacellswithdifferentemtphenotypesidentifiesquasimesenchymaltumorcellsasthosewithhighestplasticity
AT hendriklehnert acomparativeendocrinetransdifferentiationapproachtopancreaticductaladenocarcinomacellswithdifferentemtphenotypesidentifiesquasimesenchymaltumorcellsasthosewithhighestplasticity
AT jensuwemarquardt acomparativeendocrinetransdifferentiationapproachtopancreaticductaladenocarcinomacellswithdifferentemtphenotypesidentifiesquasimesenchymaltumorcellsasthosewithhighestplasticity
AT hendrikungefroren acomparativeendocrinetransdifferentiationapproachtopancreaticductaladenocarcinomacellswithdifferentemtphenotypesidentifiesquasimesenchymaltumorcellsasthosewithhighestplasticity
AT paulamschmidtlein comparativeendocrinetransdifferentiationapproachtopancreaticductaladenocarcinomacellswithdifferentemtphenotypesidentifiesquasimesenchymaltumorcellsasthosewithhighestplasticity
AT claravolz comparativeendocrinetransdifferentiationapproachtopancreaticductaladenocarcinomacellswithdifferentemtphenotypesidentifiesquasimesenchymaltumorcellsasthosewithhighestplasticity
AT rudigerbraun comparativeendocrinetransdifferentiationapproachtopancreaticductaladenocarcinomacellswithdifferentemtphenotypesidentifiesquasimesenchymaltumorcellsasthosewithhighestplasticity
AT isabelthurling comparativeendocrinetransdifferentiationapproachtopancreaticductaladenocarcinomacellswithdifferentemtphenotypesidentifiesquasimesenchymaltumorcellsasthosewithhighestplasticity
AT olhalapshyna comparativeendocrinetransdifferentiationapproachtopancreaticductaladenocarcinomacellswithdifferentemtphenotypesidentifiesquasimesenchymaltumorcellsasthosewithhighestplasticity
AT ulrichfwellner comparativeendocrinetransdifferentiationapproachtopancreaticductaladenocarcinomacellswithdifferentemtphenotypesidentifiesquasimesenchymaltumorcellsasthosewithhighestplasticity
AT bjornkonukiewitz comparativeendocrinetransdifferentiationapproachtopancreaticductaladenocarcinomacellswithdifferentemtphenotypesidentifiesquasimesenchymaltumorcellsasthosewithhighestplasticity
AT hendriklehnert comparativeendocrinetransdifferentiationapproachtopancreaticductaladenocarcinomacellswithdifferentemtphenotypesidentifiesquasimesenchymaltumorcellsasthosewithhighestplasticity
AT jensuwemarquardt comparativeendocrinetransdifferentiationapproachtopancreaticductaladenocarcinomacellswithdifferentemtphenotypesidentifiesquasimesenchymaltumorcellsasthosewithhighestplasticity
AT hendrikungefroren comparativeendocrinetransdifferentiationapproachtopancreaticductaladenocarcinomacellswithdifferentemtphenotypesidentifiesquasimesenchymaltumorcellsasthosewithhighestplasticity